{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihgtz3frwzauxsfkvf54ljxkcyiaiebjx5zjxiirvtor3i4ieqrru",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3migxzrtpv3o2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihiprwuktab25zkpcbby4ijtjo3fsxbbrrbzv7rurcqtbrn6uziwq"
    },
    "mimeType": "image/jpeg",
    "size": 134336
  },
  "path": "/news/2026-04-safer-opioid-dfnz-discovery-pain.html",
  "publishedAt": "2026-04-01T11:00:03.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Researchers at the National Institutes of Health (NIH) have identified a novel, highly potent opioid that shows potential as a therapy for both pain and opioid use disorder. In a study published in Nature, the team observed the new drug's effect in laboratory animals. They showed that it has high pain-relieving effects without causing respiratory depression, tolerance or other indicators of potential for addiction in humans.",
  "title": "A safer opioid? DFNZ discovery suggests pain relief with minimal addictive properties"
}